2 Ethics in Publishing

2.1 Originality

Manuscripts submitted by the author to the JOFH must be of original work. JOFH is strongly against plagiarism and self- plagiarism and will ensure that all manuscripts submitted should be free from any plagiarism, falsifications, or omission of significant material. Authors must not submit papers of the same work to multiple journals at the same time. Duplicated submission papers detected by the JOFH will render immediate rejection. Please cite or quote appropriately if work/words of others are being used. Avoid excessive self-citation as it might violate the reviewing process. Paper received must have a Turnitin plagiarism score below 25%.

2.2 Authorship

All authors that are named on the manuscript must have made contribution to the paper, whether in the design and/or analysis and interpretation of the data/or drafting of the paper. All authors must have critically reviewed and approved the contents of the final version of the manuscript submitted for publication.

2.3 Conflict of Interest/Competing of Interest

Avoid any possible conflict of interest, or appearance of conflict of interest during the submission process. Since the JOFH practices peer-reviewing, authors are to be reminded not to nominate reviewers that are of the same institution and the authors of the manuscript. Authors should not nominate any individuals whom they know have already read and provided comments on the manuscript or a previous version of the manuscript since such knowledge would automatically violate the reviewing process. Suggested peer-reviewers will be considered in the reviewing process by the JOFH. If there is no response from the suggested peer- reviewers, the JOFH has the rights to nominate reviewers of the article.

2.4 Acknowledgement

Authors are required to disclose the source of funding of their research at the acknowledgment according to the following format: The research work was funded by Grant’s name (Grant No.). Contributors to the article other than the authors listed should be included under the Acknowledgment with specific necessary details.

2.5 Timeliness

Authors are advised to be prompt with their manuscript revisions. If in any complications that renders the Authors to delay their manuscript revision, the Authors are responsible to inform the Editorial Office to request for an extension (technical- editor@jofh.org). Manuscript with no returned revised submission will be withdrawn from JOFH in effect after the expiration date given. In any case that the author wishes to withdraw a manuscript that has been submitted for intended publication in JOFH, the author must inform the Editorial Office of their withdrawal with appropriate reasons.

2.6  Copyright Assessment and Permissions

The authors have the full copyright holder of the published papers in JOFH. Permission must be obtained from the copyright holder concerned if all or any parts of previously published illustrations are used. Authors hold the responsibility in obtaining the permissions and provide them to the JOFH.

2.7  Notes

2.7.1  Human and Animal Research Protocol: Reports of human studies must include a statement that the protocol was approved by the appropriate institutional committee or that it complied with the Helsinki

Declaration as revised in 1983.

2.7.2  Clinical Trials

Registration is required for all clinical trials that began after July 1, 2010. When preparing reports of randomized, clinical trials, refer to the checklist published in the CONSORT Statement (CONSORT Group. CONSORT: Transparent Reporting of Trials [Internet]. Ottawa (ON): CONSORT Group; 1996 [updated 2010; cited 2016 Oct 26]. Available from http://www .consort- statement.org/). Include a CONSORT flow diagram as a

manuscript figure summarizing participant flow with the sizes (n) of initial (recruited, enrolled) and final groups. Indicate in both the abstract and the manuscript text whether the outcomes reported are primary or secondary outcomes of the study.

2.7.3 Systematic Reviews and Meta- Analyses

For systematic reviews and meta-analyses, refer to the PRISMA checklist and include a PRISMA flow diagram as a figure in the manuscript (Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. PRISMA: Transparent Reporting of Systematic Reviews and Meta-Analyses [Internet]. Ottawa (ON): Ottawa Hospital Research Institute; 2009 [updated 2009; cited 2016 Oct 26]. Available from http://www.prisma- statement.org/).

2.7.4 Animal Research
Research on animals should include a statement that the protocol was approved by the appropriate committee or complied with the Guide for the Care and Use of Laboratory Animals (National Research Council. Guide for the Care and Use of Laboratory Animals. 8th Edition. Washington, DC: National Academies Press; 2011). Compliance with the ARRIVE guidelines is encouraged (Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. ARRIVE guidelines [Internet]. London (England): National Centre for the Replacement Refinement & Reduction of Animals in Research; 2010 [last update unknown; cited 2016 Oct 26]. Available from: http://www .nc3rs.org.uk/arrive- guidelines). Describe how animals  were euthanized. Describe control and experimental animals or participants, giving age, weight, sex, race, and for animals, breed or strain. Include the supplier of experimental animals.

2.7.5 Health Research
Reporting checklists of CONSORT, PRISMA, and ARRIVE checklists can be uploaded as supplemental material for the benefit of reviewers and editors.